Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
Authors: Malek Alexandre E Published on:
2021
Publication:- DOI:-
The use of granulocyte colony-stimulating factor (G-CSF) in patients with haematological malignancies is associated with less febrile neutropenia episodes. But in the presence of COVID-19 infection, the administration of G-CSF is challenging as it may trigger a robust inflammatory reaction resulting in cytokine storm, respiratory failure and severe outcomes.
Article Analysis: --
No tags are applied.
No tags found.
Additional Information
Journal:
-
Source:
WHO: l8b4jzz4
issn_isbn:
-
Country:
-
Language:
-
article_id: 564605
More Info | #564605: Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
View PDF / Links: (#564605Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?)